Orchid Pharma registers Rs 407 crore turnover in Q1 FY13
Registers a loss of Rs 54.02 crore at the net level
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
‘Mylan can set a new standard in the treatment of HIV/AIDS in India’
Mylan recently started commercial operations in India with the launch of 18 ARVs, including heat stable, combination, and…
IAVI and DBT partner for HIV vaccine research
Seed funding of upto Rs 70 crore already invested in a HIV Vaccine Translational Research Laboratory, to be operational in the…
Pharmexcil to host ‘India – Asia-Pacific International Pharma Business Meet’
Event in Hyderabad from September 26 to 28, 2012 to see participation from 60 overseas buyers
Parabolic Drugs’ Q1 FY 13 sales up 64 per cent to Rs 305.2 crore
Board of directors recommends dividend of 0.25 paisa per share
NEJM publishes results of two phase III studies of ocriplasmin
If approved, this could be the first pharmaceutical therapy to treat patients with vitreomacular adhesion
Pharma delegation from India to visit Sri Lanka
The 20-member delegation will also attend Arogya 2012
Novozymes ties up with Holck-Larsen Foundation
To set up a scientist exchange programme between India and Denmark
Quintiles acquires Expression Analysis to advance personalised medicine
To yield actionable insights and more effective personalised treatments